Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Oct 2010

Li Xia, Wang Li, Gu Jian-Wen, Li Bing, Liu Wei-Ping, Wang Yan-Gang, Zhang Xiang, Zhen Hai-Ning, Fei Zhou

Abstract excerpt

Malignant gliomas display over-expression of the receptor tyrosine kinase EphA2. However, expression levels of the EphA2 ligand, EphrinA1, have not been fully elucidated. Seventy-eight patients with primary gliomas were included in this study who underwent surgical resection, radiation, and chemo...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Down-Regulation

Share to Glioma

Share to Immunoblotting

Share to Kaplan-Meier Estimate

Share to Mice, Nude

Share to RNA, Small Interfering

Source

Identifiers

PMID: 20571968
DOI: 10.1007/s13277-010-0060-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-20571968-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma.PMID 20571968Read ↗

EphA2 as a Novel Molecular Marker and Target in Glioblastoma MultiformeSemantic proximity Read ↗

EphA2 Receptor Tyrosine Kinase as a Promising Target for Cancer TherapeuticsSemantic proximity Read ↗

Comprehensive analysis of EphA2 in pan-cancer: A prognostic biomarker associated with cancer immunity.Semantic proximity Read ↗

Biological significance of EPHA2 expression in neuroblastoma.Semantic proximity Read ↗

Overexpression of EZH2 is associated with clinicopathological parameters and poor prognosis in gliomasSemantic proximity Read ↗

Interaction with AEG-1 and MDM2 is associated with glioma development and progression and correlates with poor prognosisSemantic proximity Read ↗

Molecular Characteristics and Prognostic Role of EPHA2 in Human Tumors via Pan-cancer AnalysisSemantic proximity Read ↗

Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patients.Semantic proximity Read ↗

Downregulation of CDKN2A and suppression of cyclin D1 gene expressions in malignant gliomasSemantic proximity Read ↗

Activation of the NRF2 pathway and its impact on the prognosis of anaplastic glioma patients.Semantic proximity Read ↗

Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.Semantic proximity Read ↗

Epidermal Growth Factor Receptor and its Oncogenic EGFRvIII Variant in Benign and Malignant Brain Tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.